Replies to post #639 on Biotech Ideas

[bladerunner1717]

PIper Sandler raises price target on CRDF from $5 to $7. Stock up 25%.

Bladerunner

[bladerunner1717]

re: CRDF

I don't see how any analyst writing about CRDF can fail to mention Pfizer's involvement with the company. Pfizer has taken a tiny equity stake in CRDF and Adam Schayowitz (from Pfizer) has been added to the BOD. The trials changed direction after Schayowitz's appointment and Pfizer is now running the lead trial in CRC.

Bladerunner